Texas Children's Health Plan will be closed on Friday, July 4th, in observance of Independence Day. In our absence, you can reach our after-hours nurse help line at 1-800-686-3831. We will resume normal business hours on Monday, July 7th. Wishing you a safe and happy Independence Day!
El Plan de Salud Infantil de Texas estará cerrado el viernes 4 de julio por el Día de la Independencia. Durante nuestra ausencia, puede comunicarse con nuestra línea de ayuda disponible las 24 horas, los 7 días de la semana, al 1-800-686-3831. Reanudaremos nuestro horario habitual el lunes 7 de julio. ¡Le deseamos un feliz y seguro 4 de julio!
Cold and flu seasonTemporada de influenza y resfriados
ALERT:Stay healthy this cold and flu season!Learn more
ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados!Más información
Call to action: The purpose of the communication is to inform prescribers of changes to the annual CMS Drug Utilization Review (DUR) Survey. The survey contains a new, required section of responses related to the Texas Prescription Drug Monitoring Program (PDMP). This year's survey is for data material from Federal Fiscal Year (FFY) 2023 (Oct. 1, 2022, to Sept. 30, 2023). Link to survey: CMS DUR Annual Survey–Provider PDMP Survey
How this impacts providers: This voluntary provider survey created by Health and Human Services Commission (HHSC) will assist HHSC in gathering the required data needed to report on Texas's PDMP usage and meet federal reporting requirements for the following DUR Survey question:
The percentage of covered providers (as determined pursuant to a process established by the State) who checked the prescription drug history of a covered individual through a PDMP before prescribing a controlled substance to such an individual.
How this information was obtained (through provider survey, provider attestation, PDMP vendor report, raw PDMP data using the median, or another method).
Survey Directions:
HHSC disseminated this survey across multiple platforms, meaning you may receive multiple invitations to complete it. Complete the survey only once.
The survey should be completed once by each individual prescriber.
Prescriber’s feedback is invaluable, and completing the survey once, ensures accurate and comprehensive data collection.
